Trial Profile
Pretreatment with ablative fractional laser and microdermabrasion before photodynamic therapy for actinic keratoses in field-cancerized skin
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Sep 2022
Price :
$35
*
At a glance
- Drugs Methyl aminolevulinate (Primary)
- Indications Actinic keratosis
- Focus Therapeutic Use
- 11 Jul 2017 Status changed from active, no longer recruiting to completed.
- 29 Jun 2016 New trial record
- 03 Jun 2016 Primary endpoint safety changed to efficacy and accordingly trial focus have been changed.Also, study design changed from "open" to "single blind".